ritonavir and Macular-Degeneration

ritonavir has been researched along with Macular-Degeneration* in 1 studies

Other Studies

1 other study(ies) available for ritonavir and Macular-Degeneration

Article	Year
Bull's eye maculopathy in an HIV-positive patient receiving ritonavir. Antiviral therapy, 2016, Volume: 21, Issue:4 Retinal toxicity involving the macula as a complication of the antiretroviral protease inhibitor ritonavir has been described in a few cases. We report retinal pigment epitheliopathy involving the macula with a bull's eye pattern in a 36-year-old man with well-controlled HIV receiving ritonavir with gradually progressive bilateral vision loss. Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; HIV Infections; Humans; Macular Degeneration; Male; Ritonavir	2016

Article

Year

Bull's eye maculopathy in an HIV-positive patient receiving ritonavir.

Antiviral therapy, 2016, Volume: 21, Issue:4

Retinal toxicity involving the macula as a complication of the antiretroviral protease inhibitor ritonavir has been described in a few cases. We report retinal pigment epitheliopathy involving the macula with a bull's eye pattern in a 36-year-old man with well-controlled HIV receiving ritonavir with gradually progressive bilateral vision loss.

Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; HIV Infections; Humans; Macular Degeneration; Male; Ritonavir

2016